相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk for Infections During Treatment With Denosumab for Osteoporosis: A Systematic Review and Meta-analysis
Talia Diker-Cohen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Sangeun Jeon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS—2020 UPDATE
Pauline M. Camacho et al.
Endocrine Practice (2020)
ENDOCRINOLOGY IN THE TIME OF COVID-19 Management of calcium metabolic disorders and osteoporosis
Neil J. Gittoes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression
Raymond Pranata et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2020)
Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19)
Rasha A. Al-Lami et al.
MAYO CLINIC PROCEEDINGS (2020)
Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019
Jia-Kui Sun et al.
Aging-US (2020)
Non-surgical management of primary hyperparathyroidism in the aging population
Cristiana Cipriani et al.
MATURITAS (2020)
Exploring links between vitamin D deficiency and COVID-19
Mradul Mohan et al.
PLOS PATHOGENS (2020)
SARS-CoV-2 (COVID-19) and the Endocrine System
Michelle D. Lundholm et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2020)
COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics
S. A. Azer
NEW MICROBES AND NEW INFECTIONS (2020)
Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review
Michael Sheehan et al.
CASE REPORTS IN ONCOLOGY (2020)
Stopping Denosumab
Olivier Lamy et al.
CURRENT OSTEOPOROSIS REPORTS (2019)
Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study
M. B. Zanchetta et al.
OSTEOPOROSIS INTERNATIONAL (2018)
Protective Effect of Denosumab on Bone in Older Women with Primary Hyperparathyroidism
Cristina Eller-Vainicher et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2018)
Primary Hyperparathyroidism
Karl L. Insogna
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus
A. A. Khan et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1)
Francesca Giusti et al.
ENDOCRINE (2016)
Cinacalcet normalizes serum calcium in a double-blind randomized, placebo-controlled study in patients with primary hyperparathyroidism with contraindications to surgery
Aliya Khan et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism
R. Cesareo et al.
OSTEOPOROSIS INTERNATIONAL (2015)
Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: Results of a prospective randomized pilot study
Simone Brardi et al.
ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA (2015)
Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab
Dharshini Karuppiah et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism
Symeon Tournis et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2014)
Medical Management of Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism
Claudio Marcocci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly
Marcello Filopanti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism
Emily M. Stein et al.
BONE (2011)
Cinacalcet HCl Reduces Hypercalcemia in Primary Hyperparathyroidism across a Wide Spectrum of Disease Severity
Munro Peacock et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism
A. Faggiano et al.
ENDOCRINE (2011)
Skeletal Effects of Interventions in Mild Primary Hyperparathyroidism: A Meta-Analysis
Shyam Sankaran et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Cinacalcet Reduces Serum Calcium Concentrations in Patients with Intractable Primary Hyperparathyroidism
Claudio Marcocci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
Paul D. Miller et al.
BONE (2008)
Hyperparathyroid crisis: Use of bisphosphonates as a bridge to parathyroidectomy
Roy Phitayakorn et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial
AA Khan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism
MR Rubin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
分享论文
